跳转至内容
Merck
CN

289507

Sigma-Aldrich

Fmoc-OSu

96%

别名:

9-芴甲基 N-琥珀酰亚胺基碳酸酯, 9-芴甲基 N-琥珀酰亚氨基碳酸酯, N-(9-芴甲氧羰基氧基)琥珀酰亚胺, Fmoc-OSu

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C19H15NO5
CAS号:
分子量:
337.33
Beilstein:
3569540
EC 号:
MDL编号:
UNSPSC代码:
12352108
PubChem化学物质编号:

方案

96%

mp

150-153 °C (lit.)

应用

peptide synthesis

官能团

Fmoc

SMILES字符串

O=C(OCC1c2ccccc2-c3ccccc13)ON4C(=O)CCC4=O

InChI

1S/C19H15NO5/c21-17-9-10-18(22)20(17)25-19(23)24-11-16-14-7-3-1-5-12(14)13-6-2-4-8-15(13)16/h1-8,16H,9-11H2

InChI key

WMSUFWLPZLCIHP-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

应用

选择性制备羟基-氨基酸 N-(9-芴甲氧羰基)衍生物的最有效试剂,反应具有高产率。比与氯甲酸酯、Fmoc-Cl 作用时的二肽形成率低。已用于合成糖肽。

其他说明

替代产品

产品编号
说明
价格

象形图

Exclamation markEnvironment

警示用语:

Warning

危险声明

危险分类

Acute Tox. 4 Oral - Aquatic Chronic 2 - Skin Sens. 1

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, type N95 (US)

法规信息

新产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Huaimin Wang et al.
Scientific reports, 5, 16680-16680 (2015-11-18)
Biocompatible peptide-based supramolecular hydrogel has recently emerged as a new and promising system for biomedical applications. In this work, Rhodamine B is employed as a new capping group of self-assembling peptide, which not only provides the driving force for supramolecular
Improved purities for Fmoc-amino acids from Fmoc-ONSu.
R C Milton et al.
International journal of peptide and protein research, 30(3), 431-432 (1987-09-01)
Occupational airborne allergic contact dermatitis from succinimidyl carbonates.
J F Fowler et al.
Contact dermatitis, 45(1), 38-38 (2001-06-26)
Ning Wang et al.
Carbohydrate research, 411, 37-41 (2015-05-15)
Monoglucosylated high-mannose-type glycan (Glc1Man9GlcNAc2: G1M9) is well-known as a key glycoform in the glycoprotein folding process, which is specifically recognized by lectin chaperones calnexin (CNX) and calreticulin (CRT) in the endoplasmic reticulum (ER). In this work, we developed an efficient
Arik Dahan et al.
Molecular pharmaceutics, 11(12), 4385-4394 (2014-11-05)
The efficacy of chemotherapeutic drugs is often offset by severe side effects attributable to poor selectivity and toxicity to normal cells. Recently, the enzyme dipeptidyl peptidase IV (DPPIV) was considered as a potential target for the delivery of chemotherapeutic drugs.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门